Association between dietary coenzyme Q10 intake and hyperuricemia in Chinese adults: a nationwide cross-sectional study
Huiying Kuang,
No information about this author
Dan Zhao,
No information about this author
Zezhong Tian
No information about this author
et al.
BMC Public Health,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 27, 2025
Language: Английский
Effectiveness of Coenzyme Q10 in Uncontrolled Diabetes Mellitus: A Double-blinded Randomized Controlled Trial
SBV Journal of Basic Clinical and Applied Health Science,
Journal Year:
2025,
Volume and Issue:
8(1), P. 3 - 6
Published: Jan. 1, 2025
Introduction:
Diabetes
mellitus
is
one
of
the
metabolic
disorders
body,
marked
with
persistent
hyperglycemia,
which
leads
to
acute
complications.
Coenzyme
Q10
(CoQ10)
a
liposoluble
antioxidant
that
might
benefit
in
lowering
blood
glucose
and
decreasing
oxidative
stress
diabetic
patients.
This
research
investigates
role
CoQ10
supplementation
affecting
HbA1c
values
patients
uncontrolled
type
2
diabetes
mellitus.
Methodology:
It
was
randomized,
double-blind,
placebo-controlled
trial
on
60
eligible
diagnosed
These
were
randomized
either
Group
Q
100
mg
per
day
or
C
placebo
for
3
months.
Baseline
data
age,
body
mass
index
(BMI),
preintervention
level
noted.
The
study
outcome
measure
interest
change
postintervention
levels
Student’s
t
-test
applied
analyze.
Results:
Compliance
similar
both
groups,
no
dropout
reported.
demographic
characteristics
similar,
mean
ages
52.66
±
10.06
years
53.4
8.9
(
P
=
0.123).
Preprocedural
8.76
0.32%
8.67
0.23%
0.44).
Postintervention
reduced
8.59
0.78%
8.47
0.67%
0.08
0.09,
respectively.
No
patient
experienced
serious
side
effects,
changes
noted
weight
participants
groups.
Conclusions:
did
not
significantly
improve
after
months
Although
has
potential
as
an
adjunct
therapy,
its
efficacy
glycemic
control
remains
questionable.
Unless
proven
benefits
are
there,
very
prudent
keep
higher
HbA1C
more
time.
Further
investigations
larger
samples
diverse
populations
required
explore
management.
Language: Английский
Trends in Coenzyme Q10 Supplement Use and Associations With All‐Cause and Cardiovascular Mortality: A Population‐Based Cohort Study
Lihan Liang,
No information about this author
Zepei Zhong,
No information about this author
Zezhong Tian
No information about this author
et al.
Molecular Nutrition & Food Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 21, 2025
Coenzyme
Q10
(CoQ10)
is
a
fat-soluble
nutrient,
which
has
antioxidant
and
anti-inflammatory
properties.
However,
there
insufficient
evidence
on
its
daily
use
the
association
with
mortality.
We
aimed
to
evaluate
trends
of
CoQ10
supplement
among
US
noninstitutionalized
adults
explore
associations
all-cause
CVD
A
prospective
cohort
study
used
data
from
National
Health
Nutrition
Examination
Survey
(1999-2018).
The
supplementation
mortality
was
assessed
Cox
proportional
hazard
models.
overall
reported
prevalence
increased
1.2%
(95%
CI
0.7%-1.8%)
in
1999-2000
4.6%
3.4%-6.1%)
2017-2018
(linear
p
=
0.002).
During
an
average
9.8
years
follow-up,
5237
deaths
were
identified,
including
1428
due
CVD.
In
multivariable
model,
not
associated
(HR
1.00,
95%
0.77-1.30,
0.996)
1.30,
0.89-1.90,
0.170).
Subgroup
analyses
suggested
that
supplements
higher
obese
participants
1.45,
1.01-2.08,
for
interaction
0.013).
Although
experienced
continuous
growth
1999
2018
general
NHANES,
Language: Английский
Associations between dietary coenzyme Q10 intake and lipid profiles in adults: a national cross-sectional study
Mingzhu Zhao,
No information about this author
Zezhong Tian,
No information about this author
Dan Zhao
No information about this author
et al.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 12, 2024
Objective
This
study
aimed
to
determine
the
average
intake
of
CoQ10
from
dietary
sources
and
explore
dose–response
relationships
between
dietary-derived
lipid
profiles.
Methods
We
performed
a
cross-sectional
based
on
China
Health
Nutrition
Survey,
which
included
7,938
adults.
The
assessment
used
three
consecutive
24-h
recalls
combined
with
household
inventory.
Serum
was
for
profiling.
Results
5.4
mg/day
in
Chinese
highest
quartile
(Q4
≥
6.96
mg/day)
negatively
associated
total
cholesterol
(TC)
[−0.12
(−0.19,
−0.06)
mmol/L],
low-density
lipoprotein
(LDL-C)
[−0.17
(−0.23,
−0.10)
non-high-density
(non-HDL-C)
(−0.18,
−0.05)
while
positively
apolipoprotein
A-1
(ApoA1)
[0.10
(0.08,
0.13)
g/L]
triglycerides
(TG)
[0.14
(0.05,
0.23)
compared
lowest
(Q1
<
1.88
mg/day).
Besides,
showed
nonlinear
associations
above
variables
(all
P
0.05).
Conclusion
Dietary-derived
may
be
some
profiles,
such
as
TG,
ApoA1,
TC,
LDL-C,
non-HDL-C.
However,
not
good
choice
individuals
who
need
supplement.
Language: Английский